iCoreConnect (ICCT) AI Stock Analysis

• Market Cap: $780.33K
• Dividend Yield: N/A
• Average Volume (3M): 80.63K
• Price to Earnings (P/E): ―
• Beta (1Y): -33.49
• Revenue Growth: 31.83%
• EPS Growth: -25.30%
• Country: US
• Employees: 67
• Sector: Healthcare
• Sector Strength: 42
• Industry: Medical - Healthcare Information Services
• EPS (TTM): -59.67
• Shares Outstanding: 4,877,080
• 10 Day Avg. Volume: 52,931
• 30 Day Avg. Volume: 80,625
• PEG Ratio: <0.01
• Price to Book (P/B): >-0.01
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -0.16
• Enterprise Value/Market Cap: 12.05
• Enterprise Value/Revenue: 0.23
• Enterprise Value/Gross Profit: 1.25
• Enterprise Value/Ebitda: -0.12
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 37 Underperform
• Price Target: $0.00 ▼(-100.00%Downside)

The primary factors influencing the score are severe financial instability, with negative equity and ongoing losses, compounded by technical weakness and poor valuation metrics. Recent bankruptcy filing and delisting proceedings further underscore significant risks, leading to a very low overall score.

iCoreConnect Business Overview & Revenue Model

Company Description

iCoreConnect Inc., a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution. It also offers iCoreExchange, a SaaS email solution that allows doctors to send and receive secure email with attachments to and from other healthcare professionals; iCoreCloud, ability to backup their on-premise servers and computers to the cloud; iCoreClaims, for processing and managing claims submitted by policyholders or dental care providers; iCorePay, a patient payment processing solutions for payment and revenue cycle tracking; iCoreSecure, secure SaaS solution that solves privacy concerns in the insurance, real estate, financial and many other industry sectors; and iCoreIT, an IT managed services. The company was formerly known as iMedicor, Inc. and changed its name to iCoreConnect Inc. in June 2017. iCoreConnect Inc. was founded in 1992 and is headquartered in Ocoee, Florida.

How the Company Makes Money

iCoreConnect generates revenue primarily through the subscription-based model of its software solutions. Customers pay recurring fees for access to the company's suite of cloud-based products, which include secure communication tools and practice management systems. These services are critical for healthcare providers who need to comply with privacy laws and improve operational efficiency. Additionally, iCoreConnect may collaborate with healthcare organizations through partnerships, expanding its reach and customer base. The company also benefits from ongoing updates and support services provided to its clients, which are factored into the subscription fees.

iCoreConnect Financial Statement Overview

Summary

iCoreConnect shows significant revenue growth but struggles with profitability due to negative net income and deeply negative EBIT and EBITDA margins. The balance sheet is concerning with high leverage and negative equity, indicating financial instability. Cash flows are negative, reflecting a cash burn despite slight improvements.

Income Statement

The company shows substantial revenue growth, with a 31.9% increase in the latest year. However, net income remains negative, reflecting ongoing losses, and both EBIT and EBITDA margins are deeply negative, highlighting continued operational challenges.

Balance Sheet

The balance sheet reveals high leverage with a negative stockholders' equity, indicating financial instability. The debt-to-equity ratio is concerning due to the negative equity, and the equity ratio is negative, reflecting more liabilities than assets.

Cash Flow

Operating and free cash flows are negative, indicating cash burn. However, there was a slight improvement in free cash flow in the latest year. The high operating cash flow to net income ratio suggests cash flow is somewhat stable relative to reported losses.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	10.75M	8.15M	7.99M	4.96M	2.12M
Gross Profit	8.25M	6.12M	5.74M	3.38M	1.11M
EBITDA	-26.73M	-11.88M	-3.51M	-1.52M	-2.35M
Net Income	-31.16M	-15.55M	-7.36M	-5.80M	-3.68M
Balance Sheet
Total Assets	5.69M	15.69M	6.56M	6.63M	2.69M
Cash, Cash Equivalents and Short-Term Investments	202.18K	1.22M	196.15K	71.81K	7.62K
Total Debt	8.85M	7.88M	6.71M	3.96M	1.58M
Total Liabilities	15.49M	11.24M	9.06M	5.63M	3.32M
Stockholders Equity	-9.79M	4.44M	-2.50M	1.01M	-628.94K
Cash Flow
Free Cash Flow	-4.63M	-9.71M	-1.57M	-3.20M	-1.81M
Operating Cash Flow	-3.23M	-8.82M	-1.27M	-2.90M	-1.27M
Investing Cash Flow	-539.42K	-10.21M	-293.96K	-3.52M	-917.90K
Financing Cash Flow	2.75M	20.06M	1.69M	6.48M	1.75M

iCoreConnect Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.16
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ICCT, the sentiment is Negative. The current price of 0.16 is below the 20-day moving average (MA) of 0.17, below the 50-day MA of 0.73, and below the 200-day MA of 2.58, indicating a bearish trend. The MACD of -0.14 indicates Negative momentum. The RSI at 33.40 is Neutral, neither overbought nor oversold. The STOCH value of 22.22 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for ICCT.

iCoreConnect Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	52 Neutral	$7.36B	-0.07	-63.77%	2.36%	16.35%	0.03%
LGMK	41 Neutral	$1.79M	―	-51.79%	―	1.56%	88.49%
ICCT	37 Underperform	$780.33K	―	-1718.32%	―	31.83%	-25.30%
NLSP	―	$7.99M	―		―	―	―
HCTI	27 Underperform	$7.88M	―	-143.99%	―	-64.77%	43.53%
STSS	―	$5.94M	―	-75.14%	―	―	―
HSCS	54 Neutral	$4.24M	―	-163.47%	―	-100.00%	78.91%

iCoreConnect Corporate Events

iCoreConnect Files for Chapter 11 Bankruptcy

On June 2, 2025, iCoreConnect Inc. and its subsidiary filed for Chapter 11 bankruptcy to maintain control over their assets and operations while restructuring for future success. The filing aims to enhance procedural efficiency and ensure operational continuity, with outstanding note payables of over $10 million affected by the automatic stay provisions.

iCoreConnect Faces Nasdaq Delisting Due to Non-Compliance

iCoreConnect Inc. has been notified by Nasdaq’s Listing Qualifications Department regarding non-compliance with certain listing requirements due to not filing its Form 10-K for the period ending December 31, 2024. Despite being granted an extension to comply, the company received a determination letter on May 20, 2025, indicating its common stock will be delisted from Nasdaq due to failure to file required forms on time. Trading suspension will begin on May 22, 2025, and the company plans to have its stock quoted on the OTC Market.

iCoreConnect Reaches Settlement to Retain Assets

On March 10, 2025, iCoreConnect Inc. received notice from PIGI Solutions, LLC about a public auction of the company’s personal property due to an alleged debt of $2,434,243. The company filed a lawsuit against PIGI and John Schneller, claiming fraudulent inducement into a finder’s fee agreement. On May 6, 2025, a Settlement and Mutual Release Agreement was reached, allowing iCoreConnect to retain control of its assets by making a payment of $3,099,747 by May 30, 2025, which would also lead to the dismissal of the lawsuit with prejudice.